Core Insights - The article highlights the performance of five prominent fund managers in the AI-themed fund sector, showcasing their investment strategies and returns in 2025, with an average return rate exceeding 43%, significantly outperforming the market index [2][9]. Group 1: Fund Managers and Performance - Li Jun (Huaxia Fund) manages the AI ETF (515070) with a return rate of approximately 46.79% in 2025, focusing on AI chips, algorithm software, and application devices, benefiting from the surge in AI computing power demand [3][9]. - Jin Zicai (Caitong Fund) leads the Caitong Growth Select fund with a return rate of about 59.13%, emphasizing technology growth stocks and making precise investments in AI computing stocks [4][9]. - Li Wenbin (Yongying Fund) oversees the Yongying Technology Driven fund, achieving a return rate of around 53%, with a focus on high-quality growth stocks in AI and semiconductors [5][9]. - Liu Gesong (Guangfa Fund) manages the Guangfa Technology Pioneer fund, which has a return rate of approximately 31%, concentrating on strategic emerging industries like new energy and AI [6][9]. - Liu Huiying (Noan Fund) leads the Noan Growth fund with a return rate of about 38%, focusing on the semiconductor and AI hardware sectors [7][9]. Group 2: Investment Styles and Risk Management - Li Jun employs a quantitative investment style, prioritizing liquidity control and minimizing tracking errors, making it suitable for passive investors [3][9]. - Jin Zicai is recognized for his industry rotation skills, focusing on high-risk, high-return strategies, with a dynamic adjustment approach to mitigate risks [4][9]. - Li Wenbin emphasizes a balanced fundamental approach, focusing on risk-reward ratios and dynamic allocation strategies [5][9]. - Liu Gesong adopts a growth-value balance strategy, emphasizing long-term investment opportunities and valuation control [6][9]. - Liu Huiying's concentrated investment style targets the semiconductor AI industry, aiming for high elasticity returns, but carries higher volatility risks [8][9].

Group 1 - The core trend observed in the second quarter of 2025 is that many prominent fund managers are increasing their positions in the innovative drug sector, indicating a growing interest in this area [1] - Yongying Fund's Gao Nan reported that the total scale of the funds he manages reached 15.326 billion yuan, a significant increase of nearly 3.5 billion yuan compared to the end of the first quarter [2] - Several funds managed by Gao Nan achieved net value growth exceeding 10%, ranking among the top in their category, showcasing a dual increase in performance and scale [2] Group 2 - The top ten holdings of Gao Nan's flagship fund, Yongying Ruixin, saw significant adjustments, with new additions from the communication equipment sector and innovative drug companies [3] - Major new holdings include companies like ZTE and Innovent Biologics, while positions in BYD and Ninebot were exited [3][4] - The three main investment directions for Gao Nan's funds are communication (TMT), innovative drugs, and light manufacturing, reflecting a clear structural adjustment in response to market themes [4] Group 3 - Gao Nan emphasizes stock selection based on company growth potential and earnings realization, aiming to reduce industry concentration while capturing growth opportunities [5] - The Yongying Technology Driven Fund plans to increase exposure to the artificial intelligence supply chain and reallocate in defense and biomedicine sectors [5] - Gao Nan expresses cautious optimism for the second half of the year, noting improved liquidity conditions and a strong financial risk prevention system established by the government [5] Group 4 - Ruiyuan Fund's Fu Pengbo also significantly increased allocations to the pharmaceutical sector, particularly in innovative drugs, during the second quarter [6] - The Ruiyuan Growth Value Mixed Fund reached a scale of 18.666 billion yuan, with a net value growth rate of 5.80%, outperforming its benchmark by 4.13 percentage points [6][7] - Fu Pengbo's portfolio is heavily weighted towards electronics, internet technology, precision manufacturing, and pharmaceuticals, with a stock position exceeding 92% [7] Group 5 - Fu Pengbo's strategy involves increasing holdings in the pharmaceutical sector, covering innovative drugs and traditional medicine benefiting from AI, while reducing exposure to traditional energy companies [10] - He plans to closely monitor mid-year reports from listed companies and seek industries and companies with rising prosperity [11] - Both Gao Nan and Fu Pengbo share a focus on innovative drugs, providing investors with a reference point for market trends and industry movements [11]

Core Viewpoint - The article discusses the investment strategy and positioning of Yongying Fund's "Intelligent Selection Series," particularly focusing on the advanced manufacturing sector and robotics, emphasizing the importance of recognizing value and understanding risks before making investment decisions [1]. Group 1: Product Positioning and Strategy - Yongying Fund is optimistic about new production capabilities and has developed the "Intelligent Selection Series" to align with national strategic directions, supporting real enterprises while providing investors with tools to seize investment opportunities in high-potential sectors [2][3]. - The "Intelligent Selection Series" combines active research and quantitative investment methods, focusing on "unicorn" industries that are scarce and have significant growth potential [2][4]. Group 2: Historical Context and Development - The company began laying out this product series in 2022, responding to market downturns and aiming for a counter-cyclical investment strategy, launching several products including the popular Yongying Semiconductor Industry Intelligent Selection and Yongying Low Carbon Environmental Protection Intelligent Selection [3][4]. - The advanced manufacturing product was quietly launched in May 2023, reflecting the company's long-term commitment to sectors like robotics and low-altitude economy as they mature [3]. Group 3: Investment Philosophy - The company believes in the unique advantages of capital markets in supporting technological innovation and aims to guide funds towards key technological enterprises, enhancing the integration of technology and industry [4][5]. - The "Intelligent Selection Series" is designed as a tool for investors to capture industry trends, with a focus on specific high-growth sectors, while other technology growth products maintain a more balanced risk distribution [9]. Group 4: Market Dynamics and Recommendations - The company acknowledges the volatility associated with high-growth sectors like advanced manufacturing but emphasizes the long-term growth potential in these areas, encouraging investors to adopt a rational approach rather than chasing short-term gains [10][11]. - The fund manager recommends a systematic investment approach, such as dollar-cost averaging, to mitigate short-term market fluctuations and to align with the long-term growth of the technology sector [12]. Group 5: Future Directions - Yongying Fund plans to continue expanding the "Intelligent Selection Series," focusing on emerging technologies and industries, while enhancing its investment management capabilities to help investors capture significant opportunities in these sectors [15].